1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Spectroscopy findings obtained from PWM, FWM, and thalamus in patients and control subjects (mean ± SD)
Patients (before Therapy) Control (Newborn, 5–7 days) P Value Patients (after therapy) Control (after 8 weeks) P Value FWM 0.88 ± 0.27 1.06 ± 0.16 N.S. 1.28 ± 0.35 1.43 ± 0.17 NS NAA/Cr FWM 2.12 ± 0.77 2.02 ± 0.46 N.S. 1.50 ± 0.33 1.73 ± 0.20 NS Cho/Cr Thalamus 1.09 ± 0.24 1.29 ± 0.13 <0.05 1.45 ± 0.17 1.38 ± 0.21 NS NAA/Cr Thalamus 1.78 ± 0.35 1.70 ± 0.18 NS 1.44 ± 0.15 1.37 ± 0.26 NS Cho/Cr PWM 1.04 ± 0.23 1.38 ± 0.17 <0.05 1.39 ± 0.25 1.52 ± 0.29 NS NAA/Cr PWM 1.91 ± 0.39 1.89 ± 0.42 NS 1.33 ± 0.25 1.57 ± 0.21 NS Cho/Cr
Note:—FWM indicates frontal while matter; NAA, N-acetylaspartate; Cr, creatine; Cho, choline; PWM, parietal white matter; NS, nonsignificant (P > .05).